M&A and Finance Research

Digital MSK Randomized Controlled Trial Says Kaia Health Cuts Costs by 80%

ByDennis Dailey December 17, 2021March 3, 2026

M&A and Finance

Medical Device Company Flow Raises $1.5m to Transform Treatment of Depression

Investment round led by Khosla Ventures Startup uses brain stimulation headset and therapy app to treat depression First and…

Read More Medical Device Company Flow Raises $1.5m to Transform Treatment of Depression
Digital Health Pharma & Life Sciences

Happify Launches the First Prescription Digital Therapeutics to Treat Both MDD and GAD

Read More Happify Launches the First Prescription Digital Therapeutics to Treat Both MDD and GAD
Devices Research

Study Shows Poor Quality PPE Puts Frontline Workers at Risk

Read More Study Shows Poor Quality PPE Puts Frontline Workers at Risk
Business of Healthcare M&A and Finance

Brightside Health Expands into Substance Use Disorder, Virtual Intensive Outpatient Treatment

Acquisition of Lionrock Recovery extends commitment to deliver mental health care to all who need it In line…

Read More Brightside Health Expands into Substance Use Disorder, Virtual Intensive Outpatient Treatment
Digital Health Innovation & Technology M&A and Finance

Proov to Expand Women’s Hormone Health Solutions to Advance Women’s Health and Offer More Accessible Care with $9.7M Series A Funding

Read More Proov to Expand Women’s Hormone Health Solutions to Advance Women’s Health and Offer More Accessible Care with $9.7M Series A Funding
M&A and Finance

Navidea Biopharmaceuticals Files for Chapter 11 Bankruptcy, Ending Years of Financial Struggle

Ohio-based diagnostic and immunotherapy biopharma Navidea Biopharmaceuticals has filed for Chapter 11 bankruptcy protection, marking the latest — and…

Read More Navidea Biopharmaceuticals Files for Chapter 11 Bankruptcy, Ending Years of Financial Struggle

Similar Posts